Treatment of neurodegenerative disorders through the blood–brain barrier using nanocarriers N Poovaiah, Z Davoudi, H Peng, B Schlichtmann, S Mallapragada, ... Nanoscale 10 (36), 16962-16983, 2018 | 201 | 2018 |
Advanced silk fibroin biomaterials for cartilage regeneration G Cheng, Z Davoudi, X Xing, X Yu, X Cheng, Z Li, H Deng, Q Wang ACS Biomaterials Science & Engineering 4 (8), 2704-2715, 2018 | 154 | 2018 |
Folate receptor-targeted and GSH-responsive carboxymethyl chitosan nanoparticles containing covalently entrapped 6-mercaptopurine for enhanced intracellular drug delivery in … X Wei, J Liao, Z Davoudi, H Zheng, J Chen, D Li, X Xiong, Y Yin, X Yu, ... Marine drugs 16 (11), 439, 2018 | 112 | 2018 |
Intestinal organoids containing poly(lactic‐co‐glycolic acid) nanoparticles for the treatment of inflammatory bowel diseases Z Davoudi, N Peroutka‐Bigus, B Bellaire, M Wannemuehler, TA Barrett, ... Journal of biomedical materials research Part A 106 (4), 876-886, 2018 | 111 | 2018 |
Synthesis and in vitro characterization of carboxymethyl chitosan-CBA-doxorubicin conjugate nanoparticles as pH-sensitive drug delivery systems R Hu, H Zheng, J Cao, Z Davoudi, Q Wang Journal of biomedical nanotechnology 13 (9), 1097-1105, 2017 | 105 | 2017 |
Gut organoid as a new platform to study alginate and chitosan mediated PLGA nanoparticles for drug delivery Z Davoudi, N Peroutka-Bigus, B Bellaire, A Jergens, M Wannemuehler, ... Marine drugs 19 (5), 282, 2021 | 67 | 2021 |
Soft materials as biological and artificial membranes S Tang, Z Davoudi, G Wang, Z Xu, T Rehman, A Prominski, B Tian, ... Chemical Society Reviews 50 (22), 12679-12701, 2021 | 59 | 2021 |
Self-assembled hyaluronic acid nanoparticles for pH-sensitive release of doxorubicin: synthesis and in vitro characterization R Hu, H Zheng, J Cao, Z Davoudi, Q Wang Journal of biomedical nanotechnology 13 (9), 1058-1068, 2017 | 55 | 2017 |
Development of chitosan/gelatin/keratin composite containing hydrocortisone sodium succinate as a buccal mucoadhesive patch to treat desquamative gingivitis Z Davoudi, M Rabiee, B Houshmand, N Eslahi, K Khoshroo, ... Drug development and industrial pharmacy 44 (1), 40-55, 2018 | 37 | 2018 |
Intestinal tissue engineering with intestinal stem cells Z Davoudi, Q Wang | 9 | 2017 |
Skin Tissue Engineering with Nanostructured Materials Z Davoudi, Q Wang Imaging Technologies and Transdermal Delivery in Skin Disorders, 147-168, 2019 | 4 | 2019 |
Colonic stem cells mediated drug delivery to treat ulcerative colitis Z Davoudi, Y Qi, Q Wang Nanomedicine: Nanotechnology, Biology and Medicine 14 (5), 1750, 2018 | 3 | 2018 |
Study transportation of drugs within newly established murine colon organoid systems Z Davoudi, T Atherly, DC Borcherding, AE Jergens, M Wannemuehler, ... Advanced Biology 7 (12), 2300103, 2023 | 2 | 2023 |
INTESTINAL ORGANOIDS CONTAINING PLGA NANOPARTICLES FOR THE TREATMENT OF INFLAMMATORY BOWEL Z Davoudi, N Peroutka‐Bigus, B Bellaire, M Wannemuehler, TA Barrett, ... Intestinal organoids as new treatments for inflammatory bowel disease 70, 2020 | 1 | 2020 |
Combinatorial screen of targeted agents with the PI3K inhibitors inavolisib, alpelisib, duvelisib, and copanlisib in multi-cell type tumor spheroids TS Dexheimer, Z Davoudi, NP Coussens, T Silvers, J Morris, N Takebe, ... SLAS Discovery, 100222, 2025 | | 2025 |
Combinations of RAS pathway inhibitors with targeted agents are active in spheroids of patient-derived cells with oncogenic KRAS variants from multiple cancer types Z Davoudi, TS Dexheimer, NP Coussens, T Silvers, J Morris, N Takebe, ... bioRxiv, 2024.11. 17.623998, 2024 | | 2024 |
Combination therapies in matched 3D in vitro and in vivo preclinical models of rare and recalcitrant cancers from the National Cancer Institute’s Patient-Derived Models Repository TS Dexheimer, T Silvers, R Delosh, R Reinhart, C Ogle, Z Davoudi, ... Cancer Research 83 (7_Supplement), 5720-5720, 2023 | | 2023 |
Aryl-hydrocarbon receptor inhibitors in combination with anticancer agents, especially proteasome pathway inhibitors, in a complex spheroid screen using patient-derived cell … BA TEICHER, JA Moscow, J Morris, JH Doroshow, TS Dexheimer, ... Cancer Research 83 (7_Supplement), 4555-4555, 2023 | | 2023 |
Advancing a screening platform with panels of patient-derived organoid models for drug discovery and development A Rapisarda, E Jones, C Hose, E Harris, PS Campbell, M Ortiz, ... Cancer Research 83 (7_Supplement), 5776-5776, 2023 | | 2023 |
Abemaciclib drug combination screening with other targeted therapies in complex multicellular tumor spheroids T Dexheimer, T Silvers, R Delosh, J Laudeman, R Reinhart, C Ogle, ... European Journal of Cancer 174, S62, 2022 | | 2022 |